Summary

for people ages 50 years and up (full criteria)
at Irvine, California and other locations
study started
estimated completion

Description

Summary

This is a safety and efficacy study of abicipar pegol in patients with neovascular age-related macular degeneration.

Official Title

Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration

Keywords

Macular DegenerationWet Macular DegenerationRanibizumababicipar pegolsham procedure

Eligibility

You can join if…

Open to people ages 50 years and up

  • Diagnosis of age-related macular degeneration in at least 1 eye
  • Best corrected visual acuity of 20/40 to 20/320 in the study eye
  • Best corrected visual acuity of 20/200 or better in the non-study eye

You CAN'T join if...

  • History of vitrectomy, macular surgery, or glaucoma surgery in the study eye
  • Cataract or refractive surgery in the study eye within the last 3 months

Locations

  • University of California at Irvine Gavin Herbert Eye Institute
    IrvineCalifornia92697-4375United States
  • Retina Associates of Orange County
    Laguna HillsCalifornia92653United States

Details

Status
in progress, not accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
Allergan
Links
More Information
ID
NCT02462486
Phase
Phase 3
Study Type
Interventional
Last Updated